About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Chicago | 164 Studies

Clinical Trials Alzheimer's DiseaseChicago

Alzheimer's Disease Clinical Trials in Chicago

Find 164 clinical trials for alzheimer's disease near Chicago, Illinois. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 164 trials

CompletedValproate in Dementia (VALID)The purpose of this trial is to demonstrate whether valproate therapy delays the emergence of agitation and/or psychosis in outpatients with probable Alzheimer's disease (AD) who…NCT00071721·Sun City, Arizona and 45 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's DiseaseThis is a multinational, multicenter, double-blind, placebo-controlled, parallel-group study using a Bayesian design with response adaptive randomization across placebo or 5…NCT01767311·Birmingham, Alabama and 168 others

TerminatedA Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's DiseaseThe purpose of this study is to determine the effects of CNP520 on cognition, global clinical status, and underlying AD pathology, as well as the safety of CNP520, in people at…NCT03131453·Phoenix, Arizona and 193 others

TerminatedAn Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's DiseaseThe purpose of this study is to assess the efficacy and safety of lanabecestat compared with placebo administered for 104 weeks in the treatment of early Alzheimer´s disease.NCT02245737·Phoenix, Arizona and 253 others

TerminatedPhase 3 IGIV, 10% in Alzheimer´s DiseaseThe purpose of this study is to provide evidence of efficacy and safety to support the development of IGIV, 10% as a treatment option for patients with mild to moderate…NCT01524887·Birmingham, Alabama and 68 others

CompletedDecision Making and Implementation of Aging-in-Place/Long Term Care Plans Among Older AdultsThis study seeks to better understand how older adult aging-in-place/long term care decision making and implementation is impacted by age-related changes (e.g. cognition, health…NCT03960476·Chicago, Illinois

CompletedSAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual SupportThe goal of the proposed study, is to adapt a positive emotion intervention for Alzheimer's Disease (AD) caregivers into a self-guided online format that incorporates social…NCT05562583·Chicago, Illinois

Active not recruitingA Study of JNJ-64042056 in Participants With Preclinical Alzheimer's DiseaseThe purpose of this study is to assess whether JNJ-64042056 affects the spread and build up of tau (a protein in brain) when compared with placebo, using brain scan (tau PET) to…NCT06544616·Phoenix, Arizona and 89 others

Active not recruitingLongitudinal Early-onset Alzheimer's Disease Study ProtocolThe Longitudinal Early-onset Alzheimer's Disease Study (LEADS) is a non-randomized, natural history, non-treatment study designed to look at disease progression in individuals…NCT03507257·Sun City, Arizona and 22 others

RecruitingA Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's DiseaseNCT06976203·Fullerton, California and 126 others

RecruitingCharacterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's DementiaThis current translational project, funded by NIH, aims to better understand the impact of various signal modification strategies for older adults with Alzheimer's dementia and…NCT04240561·Chicago, Illinois and 1 other

CompletedA Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s DiseaseThe purpose of this study was to evaluate the efficacy and safety of 2 doses of Immune Globulin Intravenous (IGIV), 10% administered every 2 weeks as an intravenous (IV) infusion…NCT00818662·Birmingham, Alabama and 40 others

CompletedA Biomarker Database to Investigate Blood-Based and Digital Biomarkers in Participants Screened for Alzheimer's Disease (Bio-Hermes)The purpose of this study (Bio-Hermes) is to develop a blood, digital, and brain amyloid PET scan biomarker database that can be used to determine whether a meaningful…NCT04733989·Aventura, Florida and 15 others

CompletedEffect of LY450139 on the Long Term Progression of Alzheimer's DiseaseAlzheimer's disease (AD) is a fatal degenerative disease of the brain for which there is no cure. AD causes brain cells to die.NCT00594568·Birmingham, Alabama and 147 others

TerminatedA Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to assess the long-term safety and tolerability of Bapineuzumab (AAB-001, ELN115727) in subjects with Alzheimer's disease who participated in study…NCT00937352·Birmingham, Alabama and 190 others

CompletedENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)The purpose of this study was to evaluate the safety and efficacy of revusiran (ALN-TTRSC) in patients with transthyretin (TTR) mediated Familial Amyloidotic Cardiomyopathy.NCT02319005·Bakersfield, California and 60 others

CompletedMemesto Wearable Device for Persons With DementiaAn estimated 70% of the 7.2+ million people in the U.S. with Alzheimer's Disease and Alzheimer's Disease-Related Dementias experience agitation, characterized by poorly organized…NCT05153161·Chicago, Illinois

Enrolling by invitationThe Diabetes Prevention Program Outcomes Study AD/ADRD ProjectThe DPPOS AD/ADRD project will address the overarching question: What are the determinants and the nature of cognitive impairment among persons with pre-diabetes (PreD) and type 2…NCT05704309·Phoenix, Arizona and 26 others

CompletedTelephone Resources and Assistance for Caregivers (TRAC)The purpose of this randomized clinical trial is to test a 12-month multi-component health promotion intervention with home-based family caregivers of persons with Alzheimer's…NCT00721383·Stanford, California and 1 other

CompletedA Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's DiseaseAZD0530 is an inhibitor of Src and Abl family kinases1. It has been developed as treatment for malignancies because these kinases play a role in tumor invasion and proliferation.NCT02167256·Phoenix, Arizona and 21 others

PreviousPage 3 of 9Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia